Single-cell analysis reveals that GFAP+ dedifferentiated Schwann cells promote tumor progress in PNI-positive distal cholangiocarcinoma via lactate/HMGB1 axis
Ziyang Zu(First Affiliated Hospital of Zhengzhou University), Wenlong Zhai(Zhengzhou University), Hongwei Tang(Dalian Medical University), Kaizhao Hu(Zhengzhou University), Jianxiang Shi, Kunlun Chen(First Affiliated Hospital of Zhengzhou University), Chong Zhang(Anhui Medical University), Ruo Feng(Zhengzhou University), Chengyang Ji(First Affiliated Hospital of Zhengzhou University), Xiaojing Shi(Zhengzhou University), Enchi Liu(University of Washington)
Cited by 14
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
|The Lancet Neurology|2010|696
Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer
|Molecular Cancer|2022|652
Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease
|Nature Communications|2020|539